FindTrial
Sign In

prophylactic erythropoietin

Erythropoietin as a prophylactic measure against anemia in critically ill patients: A Combined Prospective and Retrospective Study.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201803003169385
Enrollment
100
Registered
2018-03-07
Start date
2018-03-09
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Haematological Disorders anemia in critically ill patients

Interventions

routine ICU protocol of anemia management without prophylactic erythropoietin
prophylactic erythropoietin

Sponsors

Asmaa Fawzy Amer
Lead Sponsor
Mona B. El Mourad
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Critically ill patients aged more than 18 y of both sex who can tolerate enteral feeding with full-calorie within 48 hours after admission to ICU with Hematocrit more than 38%, without vit B12 , folate ,iron deficiency at time of admission

Exclusion criteria

Exclusion criteria: Pregnancy or lactation, Active bleeding, Presence of any primary hematologic disease. Subjects prohibited from receiving blood transfusions. Recent thromboembolic disease (within 6 months) Chronic renal failure . Liver failure . Recent cytotoxic or immunosuppressive therapy (within 1 month). patients who cannot tolerate enteral feeding throughout period of study

Design outcomes

Primary

MeasureTime frame
incidence of anemia in intervention group after prophylactic erythropoietin—

Secondary

MeasureTime frame
rate of blood transfusion in both group ;length of ICU stay;morbidity rate ;mortality rate—

Countries

Egypt

Contacts

Public ContactMona El Mourad

lecturer

monamorad80@gmail.com01019425213

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026